Session » SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)
-
Abstract Number: 0855
Asymptomatic Coronary Artery Disease Assessed by Coronary Computed Tomography in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis
-
Abstract Number: 0856
Identifying COVID-19 Infection Rates and Outcomes in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0857
Association of Telomere Length with Phenotypic Frailty in Systemic Lupus Erythematosus
-
Abstract Number: 0858
Effect of COVID Infection and COVID Vaccination on SLE Activity, Including Antiphospholipid Antibodies
-
Abstract Number: 0859
Evaluation of the Montreal Cognitive Assessment as a Screening Tool for Cognitive Dysfunction in Systemic Lupus Erythematosus
-
Abstract Number: 0860
Associations Between Tricarboxylic Acid Cycle Plasma Metabolites and Fatigue Phenotypes in Black Females with Systemic Lupus Erythematosus: An Untargeted Metabolomics Analysis
-
Abstract Number: 0861
Systemic Lupus Erythematosus, a Pilot Study of a New Disease Activity Score
-
Abstract Number: 0862
Prevalence and Risk Factors for Herpes Zoster Reactivation in 1542 Patients with Rheumatic Diseases
-
Abstract Number: 0863
Serum Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) and Cardiovascular Risk in Systemic Lupus Erythematosus: A Longitudinal Cohort Study
-
Abstract Number: 0864
Does Obesity Affect Disease Activity Outcomes in Systemic Lupus Erythematosus?
-
Abstract Number: 0865
Lupus Low Disease Activity State Attainment Provides Significant Protection Against Mortality: A Multi-National, Longitudinal Observational Study
-
Abstract Number: 0866
Characteristics Associated with Poor COVID-19 Outcomes in People with Systemic Lupus Erythematosus (SLE): Data from the COVID-19 Global Rheumatology Alliance (GRA)
-
Abstract Number: 0867
A Proteomic/Transcriptomic Analysis Associates with Subclinical Vascular Disease in Systemic Lupus Erythematosus
-
Abstract Number: 0868
Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity
-
Abstract Number: 0869
Comparison of Two Frailty Definitions in Women with Systemic Lupus Erythematosus
-
Abstract Number: 0870
Blood Brain Barrier Integrity and Brain Imaging Patterns in Patients with SLE
-
Abstract Number: 0871
The Association of Hydroxychloroquine Dosing with Adverse Cardiovascular Events in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0872
Lack of Association Between Cognitive Test Performance and Cognitive Symptoms in Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 0873
Clinical and Serological Characteristics of Latin American Patients with Lupus Enteritis: A Case-Control Study
-
Abstract Number: 0874
Serum Galectin-9 and CXCL-10 but Not Their Urinary Levels Reflect Lupus Activity
-
Abstract Number: 0875
Renal Function, Adherence and Low Hydroxychloroquine Dosing Predict HCQ Blood Levels and Lupus Disease Activity
-
Abstract Number: 0876
Antibody Response in Patients with Systemic Lupus Erythematosus After a Two-dose Regimen with SARS-CoV-2 Vaccines (Preliminary Results)
-
Abstract Number: 0877
Association of HCQ Blood Levels with Type 1 and 2 SLE Activity
-
Abstract Number: 0878
Investigating the Neutrophil to Lymphocyte Ratio as a Marker of SLE Disease Activity, Health-Related Quality of Life and Depression
-
Abstract Number: 0879
Anti-dsDNA Antibodies Increase Systemic Lupus Erythematosus Cardiovascular Risk Impairing the Immune and Cardiovascular Systems
-
Abstract Number: 0880
Health Information Use by SLE Patients Pre and During COVID-19
-
Abstract Number: 0881
Economic Evaluation of Neuropsychiatric (NP) Lupus in an International Inception Cohort Using a Multistate Model Approach
-
Abstract Number: 0882
COVID-19 Impact Among Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0883
Multimorbidity Burden in Systemic Lupus Erythematosus: A Nationwide Study
-
Abstract Number: 0884
Genetics of Longitudinal Disease Activity in Adults with Systemic Lupus Erythematosus
-
Abstract Number: 0885
SLE Phenotypes Formed from Machine Learning and Their Associations with Cognitive Impairment
-
Abstract Number: 0886
Determinants of Accessing Social and News Media and Experiencing Negative Impacts During COVID-19 in an International SLE Sample
-
Abstract Number: 0887
Association of Mycophenolate and Azathioprine Use with Cognitive Function in SLE
-
Abstract Number: 0888
Disease Flares in Lupus Are Concordant with Ruminococcus Blautia Gnavus Blooms Within Unstable Gut Microbiota Communities
-
Abstract Number: 0889
Association of Subjective Cognitive Report Using PDQ-20 to a Neuropsychological Battery in a Cohort of SLE Patients
-
Abstract Number: 0891
Quality of Life Assessment in an Indian Inception Cohort (INSPIRE) of SLE Using Lupus QoL Questionnaire
-
Abstract Number: 0892
Screening for Cognitive Impairment with the Automated Neuropsychological Assessment Metrics in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0893
Trajectories of Depressive Symptoms in Systemic Lupus Erythematosus over 7 Years
-
Abstract Number: 0894
Help-seeking Behaviors and Treatment Preferences for Sleep Problems Among Persons with Lupus
-
Abstract Number: 0895
Insight into Intraindividual Variability Across Neuropsychological Tests and Its Association with Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0896
Systemic Lupus Erythematosus Disease Flares After SARS-CoV-2 Vaccination